[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-461456-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-461456-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","personalizing-functional-assessment-in-chronic-obstructive-pulmonary-disease-a-validation-study-of-the-patient-specific-functional-scale","Personalizing Functional Assessment in Chronic Obstructive Pulmonary Disease - A Validation Study of the Patient-Specific Functional Scale","","Personalized and accurate assessment of functional performance in chronic obstructive pulmonary disease (COPD) requires patient-centered tools that capture individualized activity limitations. The Patient-Specific Functional Scale (PSFS) is brief and clinically accessible, yet its psychometric properties in COPD were not fully established. This longitudinal validation evaluated PSFS reliability and construct validity in COPD patients using test–retest outcomes and correlations with established functional questionnaires.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/personalizing-functional-assessment-in-chronic-obstructive-pulmonary-disease-a-validation-study-of-the-patient-specific-functional-scale/461456/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/personalizing-functional-assessment-in-chronic-obstructive-pulmonary-disease-a-validation-study-of-the-patient-specific-functional-scale/461456.png","ImageObject",300,407,{"name":42,"@type":43},"Danger Angel","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-30",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of this validation study of the PSFS in COPD?","Question",{"text":63,"@type":64},"To evaluate the reliability and construct validity of the Patient-Specific Functional Scale (PSFS) in individuals with COPD.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the PSFS reliability assessed in this study?",{"text":68,"@type":64},"The PSFS was administered twice, 4–7 days apart, to examine test–retest reliability and related measurement properties.",{"name":70,"@type":61,"acceptedAnswer":71},"With which instruments was construct validity evaluated?",{"text":72,"@type":64},"Construct validity was assessed by correlations between PSFS and the Duke Activity Status Index (DASI), and the St. George’s Respiratory Questionnaire (SGRQ).",{"name":74,"@type":61,"acceptedAnswer":75},"What were the key findings regarding measurement effects and demographic influence?",{"text":76,"@type":64},"No floor or ceiling effects were observed, and PSFS scores were not associated with demographic variables or COPD severity.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},461456,1790792483,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,118,123,126,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":116,"slug":117},30,"research-report",{"id":119,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":121,"slug":122},9,"Religion & Spirituality",20,"religion-spirituality",{"id":121,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":121,"slug":125},"World Cup","world-cup",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":127,"slug":129},10,"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},962090769052,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Article  \nPersonalizing Functional Assessment in Chronic Obstructive Pulmonary Disease: A Validation Study of the Patient-Specific Functional Scale  \nAsma Alonazi 1, Monira I. Aldhahi 2, Rakan Nazer 3 and Ali Albarrati 4, *  \nAcademic Editors: Sukhwinder  \nSingh Sohal and Silvano Dragonieri Received: 18 November 2025  \nRevised: 9 December 2025  \nAccepted: 18 December 2025  \nPublished: 20 December 2025  \nCopyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Physical Therapy and Health Rehabilitation, College of Applied Medical Sciences, Majmaah University, Al-Majmaah 11952, Saudi Arabia; [a.alonazi@mu.edu.sa](a.alonazi@mu.edu.sa)  \n2 Department of Rehabilitation Sciences, College of Health and Rehabilitation Sciences, Princess Nourah bint Abdulrahman University, Riyadh 11671, Saudi Arabia; [mialdhahi@pnu.edu.sa](mialdhahi@pnu.edu.sa)  \n3 Cardiac Sciences Department, College of Medicine, King Saud University, Riyadh 11421, Saudi Arabia; [raknazer@ksu.edu.sa](raknazer@ksu.edu.sa)  \n4 Rehabilitation Sciences Department, College of Applied Medical Sciences, King Saud University, Riyadh 11433, Saudi Arabia  \n* Correspondence: [albarrati@ksu.edu.sa](albarrati@ksu.edu.sa)  \nAbstract  \nBackground: Personalized and accurate assessment of functional performance in chronic obstructive pulmonary disease (COPD) requires patient-centered tools that capture individualized activity limitations. The Patient-Specific Functional Scale (PSFS) is brief and clinically accessible, but its psychometric properties in COPD have not been fully established. This study aimed to evaluate the reliability and construct validity of the PSFS in individuals with COPD. Methods: A longitudinal psychometric evaluation was conducted with 70 adults diagnosed with COPD confirmed by spirometry. The PSFS was administered twice, 4–7 days apart, to examine test–retest reliability, standard error measurement (SEM), and minimal detectable change at 95% confidence interval (MDC 95%) . Construct validity was assessed through correlations between the PSFS, the Duke Activity Status Index (DASI), and the St. George’s Respiratory Questionnaire (SGRQ) . Floor and ceiling effects were also evaluated. Results: Seventy participants (mean age 63 ± 11 years) completed the study. The PSFS demonstrated excellent test–retest reliability (ICC = 0.94; 95% CI: 0.90–0.96), and low SEM (0.16 points), and the MDC 95% was 0.44 points, with no floor or ceiling effects. Construct validity was supported by moderate positive correlations with DASI (r = 0.51, p \u003C 0.001) and moderate negative correlations with SGRQ total scores (r = –0.41, p \u003C 0.001) . PSFS scores were not associated with demographic variables or COPD severity. Conclusions: The PSFS demonstrates strong psychometric properties in COPD, including excellent reliability and moderate construct validity. Its individualized approach, ease of administration, and ability to capture functional limitations beyond traditional clinical measures support its utility in both clinical practice and research for personalized functional assessment.  \nKeywords: Patient-Specific Functional Scale (PSFS); pulmonary function; chronic obstructive pulmonary disease (COPD); Duke Activity Status Index (DASI); physical activity assessment  \n1. Introduction  \nChronic Obstructive Pulmonary Disease (COPD) represents a long-term respiratory disorder characterized by airflow obstruction and chronic inflammatory responses in  \nthe airways and lungs [1] . Globally, COPD ranks among the most prevalent causes of mortality, accounting for an estimated 3.5 million deaths in 2021 and approximately 5% of all recorded fatalities [2,3] . Beyond its clinical severity, COPD imposes substantial personal and socioeconomic burdens through reduced quality of life, limitations in daily function, and escalating healthcare","cbCaikR80svrzyxg","https://ap.wps.com/l/cbCaikR80svrzyxg","pdf",231314,11,"English","# Abstract\n# Introduction\n## Background and need for patient-centered assessment\n## Limitations of conventional COPD instruments\n## Purpose and rationale for the PSFS","[{\"question\":\"What is the purpose of this validation study of the PSFS in COPD?\",\"answer\":\"To evaluate the reliability and construct validity of the Patient-Specific Functional Scale (PSFS) in individuals with COPD.\"},{\"question\":\"How was the PSFS reliability assessed in this study?\",\"answer\":\"The PSFS was administered twice, 4–7 days apart, to examine test–retest reliability and related measurement properties.\"},{\"question\":\"With which instruments was construct validity evaluated?\",\"answer\":\"Construct validity was assessed by correlations between PSFS and the Duke Activity Status Index (DASI), and the St. George’s Respiratory Questionnaire (SGRQ).\"},{\"question\":\"What were the key findings regarding measurement effects and demographic influence?\",\"answer\":\"No floor or ceiling effects were observed, and PSFS scores were not associated with demographic variables or COPD severity.\"}]","Personalizing Functional Assessment in Chronic Obstructive Pulmonary Disease - A Validation Study of the Patient-Specific Functional Scale | PDF",1790761661,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/1e5e18ac8fcffb3655c1b2faa78fbc7d.webp",983,1390,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/97359a006af6c8d049adfde0064cfd09.webp",982,1388,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/5875bb9e3e106b3ab27050deaccb800a.webp",981,1387,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/7f7f2262f137f024fdc196c0f5125488.webp",980,1385]